ZULRESSO

Serial Number 87654989
Registration 5874882
702

Registration Progress

Application Filed
Oct 22, 2017
Under Examination
May 1, 2018
Approved for Publication
Mar 6, 2018
Published for Opposition
Mar 6, 2018
Registered
Oct 1, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-10-01)
Due: Oct 01, 2025 85 days

Basic Information

Serial Number
87654989
Registration Number
5874882
Filing Date
October 22, 2017
Registration Date
October 1, 2019
Published for Opposition
March 6, 2018
Drawing Code
3

Status Summary

Current Status
Active
Status Code
702
Status Date
Feb 13, 2025
Registration
Registered
Classes
005

Rights Holder

Sage Therapeutics, Inc.

03
Address
55 Cambridge Parkway
Cambridge, MA 02142

Ownership History

Sage Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Sage Therapeutics, Inc.

Owner at Publication
03
Cambridge, MA

Sage Therapeutics, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Steven A. Abreu

USPTO Deadlines

Next Renewal Deadline
85 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-10-01)
Due Date
October 01, 2025
Grace Period Ends
April 01, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

34 events
Date Code Type Description
Feb 13, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 13, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 11, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 1, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 1, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED
Feb 10, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 1, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER
Aug 27, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 24, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 14, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Aug 14, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 22, 2019 IUAF S USE AMENDMENT FILED
Jul 22, 2019 EISU I TEAS STATEMENT OF USE RECEIVED
Apr 24, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 22, 2019 EX2G S SOU EXTENSION 2 GRANTED
Apr 22, 2019 EXT2 S SOU EXTENSION 2 FILED
Apr 22, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 19, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 17, 2018 EXT1 S SOU EXTENSION 1 FILED
Oct 17, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 17, 2018 EX1G S SOU EXTENSION 1 GRANTED
May 1, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 18, 2018 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 18, 2018 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 6, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 6, 2018 PUBO A PUBLISHED FOR OPPOSITION
Feb 14, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 31, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 30, 2018 DOCK D ASSIGNED TO EXAMINER
Dec 15, 2017 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Dec 15, 2017 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 1, 2017 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 31, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2017 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of postpartum depression
First Use Anywhere: Jun 20, 2019
First Use in Commerce: Jun 20, 2019

Additional Information

Design Mark
The mark consists of the word "Zulresso" containing a stylized crossed arms figure above the "O" in "Zulresso".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005